News

Baseline Anxiety Impacts Adjustment to Cancer


 

Women who feel chronic anxiety or who suppress anxiety in daily life are more likely to be traumatized by a diagnosis of breast cancer, compared with women who are generally less anxious, reported Yumi Iwamitsu, Ph.D., of Kitasato University, Kanagawa, Japan, and colleagues.

The investigators examined the differences in emotional responses among 21 women who had received a diagnosis of breast cancer and 72 women who had benign tumors. Their mean age was 46 years.

Each of the women completed the Profile of Mood States (POMS), the Courtauld Emotional Control Scale, and the Manifest Anxiety Scale during a first visit to an outpatient clinic for a breast biopsy (Psychosomatics 2005;46:19-24). The women completed the POMS again after a second visit at which they learned the biopsy results.

Both the breast cancer patients and the benign tumor patients were assigned to either low anxiety or high anxiety subgroups based on the Manifest Anxiety Scale scores, and either negative emotion suppression or negative emotion expression groups based on the Courtauld Emotional Control Scale scores. The researchers compared the POMS scores before and after the biopsy results among the eight subgroups.

Among the women with breast cancer, the total mood disturbance scores were significantly higher among those in the high anxiety subgroup than in the low anxiety subgroup. Those scores were higher in the negative emotion suppression group than in the negative emotion expression group.

Among women with benign tumors, those in the high anxiety subgroup showed higher overall total mood disturbance scores at the first visit, compared with women in the low anxiety subgroup. In addition, the total mood disturbance scores in the negative emotion expression group were not significantly different between the first and second clinic visits, regardless of the diagnosis.

Recommended Reading

New HIV Therapies Challenge Gynecologic Care : With more than 30 treatment options, obstetricians' knowledge of HIVdrugs should go beyond AZT.
MDedge ObGyn
Tubal Catheterization: A Low-Cost IVF Alternative?
MDedge ObGyn
Cryoablation Is Option for Breast Fibroadenomas
MDedge ObGyn
Circulating Tumor Cells Signal Outcome in Metastatic Breast Ca
MDedge ObGyn
Data Watch
MDedge ObGyn
Zoledronic Acid Protects Bone in Premenopausal Patients With Breast Ca
MDedge ObGyn
Pap Smears May Predict Bone Health
MDedge ObGyn
Alcohol, DES Exposure May Be Fibroid Risk Factors
MDedge ObGyn
Preoperative IV Rehydration Can Lower Postoperative Nausea, Pain
MDedge ObGyn
Study Compares Hemorrhoidectomy Devices
MDedge ObGyn